Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01043042 · ClinicalTrials.gov registry record
Identification of Inpatients at Risk for Poor Glycemic Control
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 33,011
- Enrollment target
NCT01043042 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 33,011 participants.
The verdict
NCT01043042 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 33,011 participants
- Enrollment target
Study Summary
Both hypoglycemia and hyperglycemia can be detrimental to hospitalized patients. However, it is not clear which patients are more likely to develop significant problems with hypoglycemia or severe hyperglycemia in the hospital. Our hypothesis is that we will be able to identify risk factors present at admission that identify patients at greater risk of poor inpatient glycemic control
Interventions
- OTHER No interventions will be used in this study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33,011 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01043042
The ClinicalTrials.gov registry entry for NCT01043042 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33,011 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No interventions will be used in this study is the first listed.
NCT01043042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01043042 about?
NCT01043042 is a clinical study titled "Identification of Inpatients at Risk for Poor Glycemic Control". Both hypoglycemia and hyperglycemia can be detrimental to hospitalized patients. However, it is not clear which patients are more likely to develop significant problems with hypoglycemia or severe hyperglycemia in the hospital. Our hypothesis is that we will be able to identify risk factors present ...
What is the current status of trial NCT01043042?
This trial is currently completed. The enrollment target is 33,011 participants. The study started on 2010-01. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01043042?
The interventions under investigation include: No interventions will be used in this study (OTHER).
Who is sponsoring clinical trial NCT01043042?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.